Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Understanding how hair follicle stem cells work can help find new ways to prevent hair loss and promote hair growth.

Both mouse and rat models are effective for testing alopecia areata treatments.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

Certain gene variations increase the risk of alopecia areata in Koreans.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Composite biomaterials can precisely control immune responses for better disease treatment.

Immune cells and cytokines significantly affect pathological scar development.

Siddha medicine helped a child regrow hair lost from alopecia areata.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

Certain genetic variations in IL-16 may increase the risk of alopecia areata.

Screening for iron levels in patients with hair loss may help find a genetic iron overload condition early.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Obesity negatively affects the endometrium, leading to higher miscarriage risk and impaired cell function.

Notch1 helps skin heal by attracting cells that aid repair.

Wnt/beta-catenin signaling in the skin helps fat cell development during hair growth and repair.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.